BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2166027)

  • 1. The mechanism of leukotriene B4 export from human polymorphonuclear leukocytes.
    Lam BK; Gagnon L; Austen KF; Soberman RJ
    J Biol Chem; 1990 Aug; 265(23):13438-41. PubMed ID: 2166027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an aldehyde dehydrogenase in the microsomes of human polymorphonuclear leukocytes that metabolizes 20-aldehyde leukotriene B4.
    Sutyak J; Austen KF; Soberman RJ
    J Biol Chem; 1989 Sep; 264(25):14818-23. PubMed ID: 2549038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes.
    Shak S; Goldstein IM
    J Biol Chem; 1984 Aug; 259(16):10181-7. PubMed ID: 6088485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B4.
    Lam BK; Xu K; Atkins MB; Austen KF
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11598-602. PubMed ID: 1333613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclical binding, processing, and functional interactions of neutrophils with leukotriene B4.
    O'Flaherty JT; Redman JF; Jacobson DP
    J Cell Physiol; 1990 Feb; 142(2):299-308. PubMed ID: 2154503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibitory effects of auranofin on leukotriene B4 and leukotriene C4 formation by human polymorphonuclear leukocytes.
    Honda Z; Iizasa T; Morita Y; Matsuta K; Nishida Y; Miyamoto T
    Biochem Pharmacol; 1987 May; 36(9):1475-81. PubMed ID: 3034290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired leukotriene B4 release by neonatal polymorphonuclear leukocytes.
    Viggiano D; Romano G; Caniglia M; Santoro P; Palumbo A; Ciccimarra F
    Pediatr Res; 1994 Jul; 36(1 Pt 1):60-3. PubMed ID: 7936838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
    Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
    Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils.
    Krump E; Picard S; Mancini J; Borgeat P
    J Exp Med; 1997 Oct; 186(8):1401-6. PubMed ID: 9334381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene B4 binding to human neutrophils.
    Lin AH; Ruppel PL; Gorman RR
    Prostaglandins; 1984 Dec; 28(6):837-49. PubMed ID: 6097945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
    Williams JD; Lee TH; Lewis RA; Austen F
    J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene A5 is a substrate and an inhibitor of rat and human neutrophil LTA4 hydrolase.
    Nathaniel DJ; Evans JF; Leblanc Y; Léveillé C; Fitzsimmons BJ; Ford-Hutchinson AW
    Biochem Biophys Res Commun; 1985 Sep; 131(2):827-35. PubMed ID: 2996528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes.
    Lärfars G; Lantoine F; Devynck MA; Palmblad J; Gyllenhammar H
    Blood; 1999 Feb; 93(4):1399-405. PubMed ID: 9949184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene A4 modulates generation of leukotriene B4 and sulphidopeptide leukotrienes by human neutrophils.
    Hilger RA; König W
    Immunology; 1992 Nov; 77(3):408-15. PubMed ID: 1335961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis and cyclic AMP accumulation in human polymorphonuclear leukocytes.
    Gorman RR; Morton DR; Hopkins NK; Lin AH
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():57-63. PubMed ID: 6303092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification and formation of 20-aldehyde leukotriene B4.
    Soberman RJ; Sutyak JP; Okita RT; Wendelborn DF; Roberts LJ; Austen KF
    J Biol Chem; 1988 Jun; 263(17):7996-8002. PubMed ID: 2836406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes.
    Goldman DW; Goetzl EJ
    J Immunol; 1982 Oct; 129(4):1600-4. PubMed ID: 6286770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of leukotriene B4 synthesis in canine polymorphonuclear leukocytes.
    Amalsadvala TM; Vaughn DM
    Prostaglandins Leukot Essent Fatty Acids; 1992 Apr; 45(4):283-8. PubMed ID: 1318548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human polymorphonuclear leukocytes release leukotriene B4 during phagocytosis of Staphylococcus aureus.
    Henricks PA; van der Tol ME; Engels F; Nijkamp FP; Verhoef J
    Inflammation; 1986 Mar; 10(1):37-47. PubMed ID: 3007355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of leukotriene A4 to leukotriene B4: catalysis by human liver microsomes under anaerobic conditions.
    Gut J; Goldman DW; Jamieson GC; Trudell JR
    Arch Biochem Biophys; 1987 Dec; 259(2):497-509. PubMed ID: 2827578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.